CN101863862B - 一种工业半合成紫杉醇的方法 - Google Patents
一种工业半合成紫杉醇的方法 Download PDFInfo
- Publication number
- CN101863862B CN101863862B CN2010102029114A CN201010202911A CN101863862B CN 101863862 B CN101863862 B CN 101863862B CN 2010102029114 A CN2010102029114 A CN 2010102029114A CN 201010202911 A CN201010202911 A CN 201010202911A CN 101863862 B CN101863862 B CN 101863862B
- Authority
- CN
- China
- Prior art keywords
- reaction
- baccatin iii
- phenyl
- doubly
- oxazolinyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229930012538 Paclitaxel Natural products 0.000 title claims abstract description 43
- 229960001592 paclitaxel Drugs 0.000 title claims abstract description 42
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 title claims abstract description 42
- 238000000034 method Methods 0.000 title claims abstract description 19
- 238000003786 synthesis reaction Methods 0.000 title claims abstract description 9
- OVMSOCFBDVBLFW-VHLOTGQHSA-N 5beta,20-epoxy-1,7beta,13alpha-trihydroxy-9-oxotax-11-ene-2alpha,4alpha,10beta-triyl 4,10-diacetate 2-benzoate Chemical compound O([C@@H]1[C@@]2(C[C@H](O)C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)O)C(=O)C1=CC=CC=C1 OVMSOCFBDVBLFW-VHLOTGQHSA-N 0.000 claims abstract description 114
- 238000006243 chemical reaction Methods 0.000 claims abstract description 105
- 229930014667 baccatin III Natural products 0.000 claims abstract description 69
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 30
- LJCZNYWLQZZIOS-UHFFFAOYSA-N 2,2,2-trichlorethoxycarbonyl chloride Chemical compound ClC(=O)OCC(Cl)(Cl)Cl LJCZNYWLQZZIOS-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000005886 esterification reaction Methods 0.000 claims abstract description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 61
- 239000000243 solution Substances 0.000 claims description 35
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 32
- 230000004224 protection Effects 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 20
- 238000001035 drying Methods 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 14
- 238000013019 agitation Methods 0.000 claims description 13
- YWLXLRUDGLRYDR-UHFFFAOYSA-N 10-deacetylbaccatin Chemical compound CC(=O)OC12COC1CC(O)C(C(C(O)C1=C(C)C(O)CC3(O)C1(C)C)=O)(C)C2C3OC(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-UHFFFAOYSA-N 0.000 claims description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 12
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 10
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- 239000012074 organic phase Substances 0.000 claims description 10
- 239000012266 salt solution Substances 0.000 claims description 10
- 229920006395 saturated elastomer Polymers 0.000 claims description 10
- 238000005406 washing Methods 0.000 claims description 10
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 8
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 8
- 238000001514 detection method Methods 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 6
- 229960000583 acetic acid Drugs 0.000 claims description 5
- 239000012295 chemical reaction liquid Substances 0.000 claims description 5
- 238000002425 crystallisation Methods 0.000 claims description 5
- 230000008025 crystallization Effects 0.000 claims description 5
- 230000008030 elimination Effects 0.000 claims description 5
- 238000003379 elimination reaction Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000012362 glacial acetic acid Substances 0.000 claims description 5
- 239000011521 glass Substances 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 5
- 238000006386 neutralization reaction Methods 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 238000000967 suction filtration Methods 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical group C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims description 3
- 239000003518 caustics Substances 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- 239000006227 byproduct Substances 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 230000035484 reaction time Effects 0.000 abstract description 6
- 239000011261 inert gas Substances 0.000 abstract description 2
- 230000000397 acetylating effect Effects 0.000 abstract 2
- 125000003834 baccatin III group Chemical group 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 238000007796 conventional method Methods 0.000 abstract 1
- 230000000640 hydroxylating effect Effects 0.000 abstract 1
- 125000002971 oxazolyl group Chemical group 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 239000007787 solid Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 7
- -1 acetyl baccatin III Chemical compound 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 239000000047 product Substances 0.000 description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 2
- 0 CC(C)([C@@](C1)([C@@](*)[C@@]([C@]2(C(C[C@@]3*)OC2)OC(C)=O)[C@]3(C)C([C@@]2OC(C)=O)=O)O)C2=C(C)[C@]1O Chemical compound CC(C)([C@@](C1)([C@@](*)[C@@]([C@]2(C(C[C@@]3*)OC2)OC(C)=O)[C@]3(C)C([C@@]2OC(C)=O)=O)O)C2=C(C)[C@]1O 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229960003668 docetaxel Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000005580 one pot reaction Methods 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- PSCJODZIMUSFCK-UHFFFAOYSA-N 4,5-dihydro-1,3-oxazole-2-carboxylic acid Chemical class OC(=O)C1=NCCO1 PSCJODZIMUSFCK-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 1
- 241001149649 Taxus wallichiana var. chinensis Species 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000006480 benzoylation reaction Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000004579 taxol derivatives Chemical class 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Epoxy Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102029114A CN101863862B (zh) | 2010-06-18 | 2010-06-18 | 一种工业半合成紫杉醇的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102029114A CN101863862B (zh) | 2010-06-18 | 2010-06-18 | 一种工业半合成紫杉醇的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101863862A CN101863862A (zh) | 2010-10-20 |
CN101863862B true CN101863862B (zh) | 2012-01-11 |
Family
ID=42955824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102029114A Active CN101863862B (zh) | 2010-06-18 | 2010-06-18 | 一种工业半合成紫杉醇的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101863862B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102993137A (zh) * | 2012-12-13 | 2013-03-27 | 云南汉德生物技术有限公司 | 一种工业半合成多西紫杉醇的方法 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102417491B (zh) * | 2011-10-31 | 2013-11-06 | 江苏红豆杉生物科技有限公司 | 以10-去乙酰基-巴卡丁iii为原料制备卡巴他赛的方法 |
CN103130753B (zh) * | 2013-03-14 | 2015-09-02 | 上海龙翔生物医药开发有限公司 | 抗肿瘤药物紫杉醇的半合成方法 |
CN103450118A (zh) * | 2013-09-18 | 2013-12-18 | 江苏红豆杉药业有限公司 | 一种半合成法制备紫杉醇的方法 |
CN108841888B (zh) * | 2018-07-31 | 2021-05-28 | 华南农业大学 | 乙酸酐作为酰基供体在参与dbat酶促反应中的应用 |
CN115260130A (zh) * | 2022-07-07 | 2022-11-01 | 上海卓鼎生物技术有限公司 | 一种10-脱乙酰基紫杉醇的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965739A (en) * | 1993-06-11 | 1999-10-12 | Pharmacia & Upjohn Company | Δ6,7 -taxols antineoplastic use and pharmaceutical compositions containing them |
CN101088994A (zh) * | 2006-06-12 | 2007-12-19 | 上海龙翔生物医药开发有限公司 | 一种紫杉醇和多西紫杉醇的合成方法 |
CN101468974A (zh) * | 2007-12-28 | 2009-07-01 | 上海百灵医药科技有限公司 | 多烯紫杉醇的半合成方法 |
-
2010
- 2010-06-18 CN CN2010102029114A patent/CN101863862B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965739A (en) * | 1993-06-11 | 1999-10-12 | Pharmacia & Upjohn Company | Δ6,7 -taxols antineoplastic use and pharmaceutical compositions containing them |
CN101088994A (zh) * | 2006-06-12 | 2007-12-19 | 上海龙翔生物医药开发有限公司 | 一种紫杉醇和多西紫杉醇的合成方法 |
CN101468974A (zh) * | 2007-12-28 | 2009-07-01 | 上海百灵医药科技有限公司 | 多烯紫杉醇的半合成方法 |
Non-Patent Citations (8)
Title |
---|
Commercon A,Bezard D,Bernard F et al..Improved protection and esterification of a precursor of the TAXOTERE and taxol side chains.《Tetrahedron Lett》.1992,第33卷(第5期),5185-5188. * |
Kanazawa A M,Denis J N,Greene A E..Direct,stereoselective synthesis of the proteced paclitaxel side chain and high yield transformation to paclitaxel..《J Chem Soc Chem Commun》.1998,第22卷2591-2592. * |
唐艳梅 |
孙浩岩 |
孙浩岩;黄兴富;唐艳梅;王继良.具有实用价值紫杉醇半合成路线概述.《中国民族民间医药》.2010,(第13期), * |
李 鹏,李春香.多西他赛的合成.《中国医药工业杂志》.2009,第40卷(第2期),90-92. * |
王继良.具有实用价值紫杉醇半合成路线概述.《中国民族民间医药》.2010,(第13期), |
黄兴富 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102993137A (zh) * | 2012-12-13 | 2013-03-27 | 云南汉德生物技术有限公司 | 一种工业半合成多西紫杉醇的方法 |
CN102993137B (zh) * | 2012-12-13 | 2015-05-20 | 云南汉德生物技术有限公司 | 一种工业半合成多西紫杉醇的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101863862A (zh) | 2010-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101863862B (zh) | 一种工业半合成紫杉醇的方法 | |
CA2572315C (en) | Semi-synthetic conversion of paclitaxel to docetaxel | |
CN100593024C (zh) | 一种紫杉醇和多西紫杉醇的合成方法 | |
CN110078686A (zh) | 10-去乙酰基巴卡亭ⅲ合成卡巴他赛的方法 | |
TW200906813A (en) | Stable anhydrous crystalline docetaxel and method for the preparation thereof | |
CN102382080B (zh) | 一种多西他赛的制备方法 | |
CN101343262A (zh) | 多西他赛的生产方法 | |
CN101585780A (zh) | 一种不对称合成手性紫杉醇侧链的方法 | |
CN106146355B (zh) | 益母草碱与阿司匹林缀合物的制备方法 | |
CN103254187B (zh) | 一种紫杉烷衍生物的制备方法 | |
CN100417649C (zh) | 一种多西他赛的制备方法 | |
CN108003119B (zh) | 由10-去乙酰基巴卡亭ⅲ合成卡巴他赛的方法 | |
CN103130753B (zh) | 抗肿瘤药物紫杉醇的半合成方法 | |
CN113620911A (zh) | 一种紫杉醇衍生物及其制备方法 | |
CN101274923B (zh) | 一种制备紫杉醇,巴卡亭ⅲ及其衍生物的方法 | |
CN110003144B (zh) | 一种三尖杉宁碱合成紫杉醇的方法 | |
CN101007795B (zh) | 紫杉醇及多烯紫杉醇的合成方法 | |
CN104250235B (zh) | 一种紫杉醇的制备方法 | |
CN1086389C (zh) | 异埃坡霉素及合成方法 | |
CN103450118A (zh) | 一种半合成法制备紫杉醇的方法 | |
WO2009040829A1 (en) | A novel process for the preparation of docetaxel | |
CN101353334A (zh) | 一种制备多西他赛的方法 | |
CN100406450C (zh) | 一种多烯紫杉醇的合成方法 | |
CN111138386A (zh) | 一种多西他赛的半合成方法 | |
CN102516207B (zh) | 一种利用7-木糖10-去乙酰基紫杉烷制备紫杉醇的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210927 Address after: 201508 room 210, building 13, Lane 16299, Puwei highway, Jinshan District, Shanghai Patentee after: Shanghai Zhuoding Biotechnology Co.,Ltd. Address before: 650000 platform 3, Jinding Science Park, Xuefu Road, Kunming, Yunnan Patentee before: YUNNAN HANDE BIO-TECH Co.,Ltd. |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Tong Qiang Document name: Deemed not to have provided notice |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Shanghai Zhuoding Biotechnology Co.,Ltd. Person in charge of patentsThe principal of patent Document name: Notice of Approval for Fee Reduction |